Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Sonos
SONO
$1.93B
| $10.8M | ﹤0.01% |
596,926
+227,245
| +61% | +$5.1M |
|
|
HIBB
2502
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $10.8M | ﹤0.01% |
246,308
+104,638
| +74% | +$4.83M |
|
2503
Digital Turbine
APPS
$1.51B
| $10.8M | ﹤0.01% |
615,572
+308,748
| +101% | +$8.37M |
|
|
FRBN
2504
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $10.8M | ﹤0.01% |
1,075,000
-1
| -0% | -$10 |
|
2505
Quest Diagnostics
DGX
$25.9B
| $10.7M | ﹤0.01% |
80,832
+77,749
| +2,522% | +$10.6M |
|
2506
Global Ship Lease
GSL
$1.52B
| $10.7M | ﹤0.01% |
650,244
+71,305
| +12% | +$1.57M |
|
|
KRTX
2507
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $10.7M | ﹤0.01% |
84,900
+50,900
| +150% | +$5.85M |
|
2508
CALL
KraneShares Global Carbon Strategy ETF
KRBN
$132M
| $10.7M | ﹤0.01% |
218,100
+40,500
| +23% | +$1.95M |
|
2509
PUT
CSX Corp
CSX
$92.9B
| $10.7M | ﹤0.01% |
369,000
-258,100
| -41% | -$8.41M |
|
2510
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$4.53B
| $10.7M | ﹤0.01% |
247,000
-401,800
| -62% | -$21.8M |
|
2511
Texas Pacific Land
TPL
$24.7B
| $10.7M | ﹤0.01% |
64,800
-3,591
| -5% | -$587K |
|
2512
Elanco Animal Health
ELAN
$11.8B
| $10.7M | ﹤0.01% |
545,183
-50,132
| -8% | -$1.19M |
|
|
KCGI
2513
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $10.7M | ﹤0.01% |
1,080,698
-527,659
| -33% | -$5.23M |
|
2514
KT
KT
$9.11B
| $10.7M | ﹤0.01% |
765,523
+645,557
| +538% | +$9.28M |
|
2515
B2Gold
BTG
$6.79B
| $10.7M | ﹤0.01% |
3,151,196
+1,513,935
| +92% | +$6.32M |
|
|
SRCL
2516
DELISTED
Stericycle Inc
SRCL
| $10.7M | ﹤0.01% |
243,513
-84,168
| -26% | -$4.17M |
|
2517
Buckle
BKE
$2.27B
| $10.7M | ﹤0.01% |
385,331
+188,499
| +96% | +$5.91M |
|
2518
ArcelorMittal
MT
$55.7B
| $10.7M | ﹤0.01% |
471,645
+626
| +0.1% | +$18.3K |
|
2519
Group 1 Automotive
GPI
$3.15B
| $10.7M | ﹤0.01% |
62,741
-44,732
| -42% | -$7.79M |
|
2520
Wipro
WIT
$19.2B
| $10.7M | ﹤0.01% |
4,012,808
+1,369,420
| +52% | +$4.31M |
|
|
RVNC
2521
DELISTED
Revance Therapeutics, Inc.
RVNC
| $10.6M | ﹤0.01% |
769,584
+104,391
| +16% | +$1.61M |
|
2522
PUT
Toyota
TM
$226B
| $10.6M | ﹤0.01% |
68,900
+12,200
| +22% | +$2.02M |
|
|
EDNC
2523
DELISTED
Endurance Acquisition Corp. Class A Ordinary Shares
EDNC
| $10.6M | ﹤0.01% |
1,078,438
-171,653
| -14% | -$1.69M |
|
2524
CALL
iShares US Home Construction ETF
ITB
$2.36B
| $10.6M | ﹤0.01% |
202,200
+37,800
| +23% | +$2.16M |
|
2525
Rollins
ROL
$17.4B
| $10.6M | ﹤0.01% |
303,971
-447,854
| -60% | -$15.4M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.